Funding for this research was provided by:
National Institutes of Health (Z01 HG200328 14, Z01 HG200359 11)
Received: 15 September 2020
Accepted: 18 March 2021
First Online: 8 April 2021
: The ClinSeq<sup>®</sup> and overgrowth studies were approved by Institutional Review Boards at the National Institutes of Health.
: No personally identifiable data is included in manuscript.
: LGB has received in kind research support from ArQule Inc (now wholly owned by Merck, Inc.) and Pfizer, Inc, honoraria from Cold Spring Harbor Press, and is an uncompensated member of the Illumina Inc. Ethics Advisory Board.